Research & Publications > Clinical
Research > Cardiovascular
Disease Prevention Center > Cardiovascular
Disease Prevention Center
(Continued)
Safety and Efficacy of Fixed Combination Metformin/Glyburide Products as First Line Therapy in Patients with Type 2 Diabetes Mellitus who have Inadequate Glycemic Control with Diet and Exercise
Sponsor: Bristol-Myers Squibb Pharmaceutical Research Institute
Dates: 2/98 - 11/00
Principal Investigator: John Morgan, MD
A Long-Term, Open-Label, Multi-Center Trial of the Safety and Efficacy of Nicostatin in Patients with Dyslipidemia
Sponsor: KOS Pharmaceuticals
Dates: 9/98 - 8/00
Principal Investigator: John Morgan, MD
A Comparative Study of Lovastatin XL with Mevacor in Patients with Hypercholesterolemia
Sponsor: Aura Laboratories
Dates: 6/99 - 5/01
Principal Investigator: John Morgan, MD
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of ZD4522 (5 and 10 mg) and Atrovastatin (10 mg) in the Treatment of Subjects with Hypercholesterolemia
Sponsor: Zeneca Pharmaceuticals
Dates: 4/99 - 5/00
Principal Investigator: John Morgan, MD
Cerivastatin for Hyperlipidemia After Reaching Menopause (CHARM): A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, 6-Week Evaluation of Cerivastatin 0.4 mg and Atorvastatin 10 mg in Post Menopausal Women with Hyperlipidemia and a 46-Week Evaluation in which Cerivastatin 0.4 mg and Cerivastatin 0.8 mg are Compared to Fenofibrate 201 mg for Long-Term Lipid-Lowering and Bone Mineral Density Effects
Sponsor: SmithKline Beecham
Dates: 8/99 - 7/00
Principal Investigator: John Morgan, MD
< Back More >
|
|
